NIDDM Clinical Trial
Official title:
ACE/ACE2 Ratio in Diabetic Patients Treated With Antihypertensive Drugs
This feasibility study is designed to examine modulation of the relative activities of ACE
and ACE2 in diabetic patients following treatment with the angiotensin type 1 receptor
(AT1R) antagonist, Candesartan.
This study will provide a closer insight to the possible involvement of the
renin-angiotensin system (RAS)-related enzymatic components in development or attenuation of
vascular pathogenesis.
n/a
Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02158741 -
Comparison Study of Usual Care vs. Usual Care Plus Community Intervention to Manage Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05949008 -
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
|
Phase 4 | |
| Terminated |
NCT00234273 -
APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics
|
Phase 2 | |
| Completed |
NCT01056367 -
Resistant Hypertension in Patients With Type-II-Diabetes Mellitus
|
N/A | |
| Completed |
NCT01027052 -
Spices Inhibit the Formation and Absorption of Malondialdehyde From Hamburger Meat
|
N/A | |
| Completed |
NCT01272804 -
Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
|
Phase 1 | |
| Completed |
NCT00410800 -
Insulin Secretory Defects in Pima Indians at High Risk for NIDDM
|
N/A |